Black Bird Biotech posts a current assets of $91K as of September 2023. That compares with $160K in the prior-year period — down 43.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Black Bird Biotech's current assets was $160K. The latest reading is $91K — a 43.1% year-over-year decrease (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Black Bird Biotech's financial statement story. At $91K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BBBT's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Black Bird Biotech's other metric pages and overview cover the third.